Prognostic Utility of Estimated Pulmonary Dead Space to Tidal Volume Fraction in Patients With COVID-19 Respiratory Failure Treated With Invasive Mechanical Ventilation
Clinical Infection and Immunity · 2021
DOI: 10.14740/cii126 ↗At a glance
Journal article in Clinical Infection and Immunity, 2021. Written by Robert L. Vender and 3 co-authors.
Topics: Beatmung und Weaning
Abstract (original language)
Background
Multiple studies have previously identified measurements of pulmonary dead space fraction (Vd/Vt) as accurate predictors of clinical outcome for patients with acute respiratory distress syndrome (ARDS). The objective of this study was to evaluate the association of Vd/Vt calculations utilizing a validated equation using clinically available data with mortality in patients with severe COVID-19 lung disease requiring invasive mechanical ventilation.
Methods
Calculations of Vd/Vt were obtained based upon equation for dead space ventilation fraction (Vd/Vt = 0.320 + 0.0106 (PaCO 2 - ETCO 2 ) + (0.003 RR) + (0.0015 age)) on patients with RT-PCR-confirmed COVID-19 following initial endotracheal intubation and initiation of invasive mechanical ventilation. Clinical patient groups were stratified based upon outcome: 1) Survivors (n = 9); 2) Non-survivors resultant from withdrawal of care (n = 2); and 3) Non-survivors with lung-related death (n = 9).
Results
Comparison of Vd/Vt data for the clinical outcome study groups (survivors versus non-survivors related to lung disease progression) demonstrated: 1) No differences in first/initial Vd/Vt calculations (0.58 (0.06) vs. 0.62 (0.06), respectively; P = 0.311); and 2) Marked and statistically significant differences in final/last Vd/Vt calculations (0.52 (0.04) vs. 0.83 (0.07), respectively; P < 0.001).
Conclusion
The prediction equation for Vd/Vt reflects mortality in this study-specific population of patients with COVID-19 respiratory failure. In addition, the progressive worsening of lung disease severity in non-survivors is mirrored by changes in Vd/Vt calculations. Clin Infect Immun. 2021;6(1):6-10 doi: https://doi.org/10.14740/cii126
Cite
APA
Vender, R. L., Frankenfield, D. C., Valencia-Moulton, P. A., & Lehman, E. B. (2021). Prognostic Utility of Estimated Pulmonary Dead Space to Tidal Volume Fraction in Patients With COVID-19 Respiratory Failure Treated With Invasive Mechanical Ventilation. Clinical Infection and Immunity. https://doi.org/10.14740/cii126
Vancouver
Vender RL, Frankenfield DC, Valencia-Moulton PA, Lehman EB. Prognostic Utility of Estimated Pulmonary Dead Space to Tidal Volume Fraction in Patients With COVID-19 Respiratory Failure Treated With Invasive Mechanical Ventilation. Clinical Infection and Immunity. 2021. doi:10.14740/cii126
BibTeX
@article{Vender2021,
author = {Vender, Robert L. and Frankenfield, David C. and Valencia-Moulton, Paula A. and Lehman, Erik B.},
title = {Prognostic Utility of Estimated Pulmonary Dead Space to Tidal Volume Fraction in Patients With COVID-19 Respiratory Failure Treated With Invasive Mechanical Ventilation},
journal = {Clinical Infection and Immunity},
year = {2021},
doi = {10.14740/cii126}
}
EUVIMED